Molecular pathways: microRNAs, cancer cells, and microenvironment

Ioana Berindan-Neagoe1, George A Calin2

  • 1Research Center for Functional Genomics and Translational Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania. Department of Immunology, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania. Department of Functional Genomics and Experimental Pathology, "Ion Chiricuta" The Oncology Institute, Cluj-Napoca, Romania. Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas. gcalin@mdanderson.org ioana.neagoe@umfcluj.ro.

Insights

MicroRNAs (miRNAs) are key players in cancer, influencing tumor growth and spread. These small molecules mediate communication between cancer cells and their environment, impacting treatment outcomes.

Area of Science:

  • Molecular Oncology
  • Cancer Biology
  • RNA Biology

Background:

  • Recent discoveries highlight the interplay between genetic mutations and microRNAs (miRNAs) in cancer.
  • MicroRNAs (miRNAs) are increasingly recognized for their roles beyond cancer cells, originating from the tumor microenvironment.
  • Extracellular miRNAs function as signaling molecules, transported via vesicles or as free molecules.

Purpose of the Study:

  • To review the role of microRNAs (miRNAs) in cancer cell-microenvironment communication.
  • To explore the translational applications of miRNAs in oncology.
  • To discuss miRNAs as biomarkers for treatment response and therapeutic targets.

Main Methods:

  • Literature review and synthesis of current research on miRNA-mediated communication in cancer.
  • Analysis of studies investigating extracellular miRNA transport and uptake.
  • Examination of clinical data and preclinical models related to miRNA therapeutics.

Main Results:

  • MicroRNAs (miRNAs) facilitate intercellular communication, influencing cancer initiation, progression, and metastasis.
  • Extracellular miRNAs, packaged in vesicles or as free molecules, act as systemic signaling agents.
  • Evidence supports miRNAs' potential as predictive biomarkers for therapeutic efficacy.

Conclusions:

  • MicroRNA-mediated communication is a critical aspect of the tumor microenvironment.
  • MicroRNAs hold significant promise as predictive biomarkers and therapeutic targets in oncology.
  • Targeting miRNAs offers a novel strategy for cancer treatment.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

3.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
25.1K
MicroRNAs01:22

MicroRNAs

12.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K